Carocell Bio’s leadership team has extensive global experience in drug development and is committed to developing new medicines for patients with inflammatory diseases

Carocell Bio executive team

Dr Mike Davies MD, FRCRS, FRSPSG
CEO & Founder

  • Over 25 years’ global executive leadership experience in drug development in pharma (Pfizer, AstraZeneca, Shire) and biotech
  • Expertise in early-stage development and taking medicines from ideation to the market
  • Founder of Carocell Bio

John Nicholson

  • International experience in the pharmaceutical and chemical industries
  • Funded and managed Analytical Services companies
  • Advisory Board member of the UK North West Business Fund
  • Previous Chairman Gentronix

Ann R. Mackey
Chief Financial Officer

  • Successful track record of leadership, launching operational initiatives, attracting talented managers, and developing effective teams.
  • Experienced with capital markets, corporate structuring, acquisitions, and venture capital.

Carocell Bio Advisory Team

Professor Fadi Issa
Consultant Burns and Plastic Surgeon

Buckinghamshire Healthcare NHS Trust Hospital & Health Care, Aylesbury , Buckinghamshire

Professor John Mclaughlin
Scientific Advisor, IBD

Professor of Gastroenterology and Nutrition, Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Biology, Medicine and Health, University of Manchester, UK

Professor Donald YM Leung
Scientific Advisor, AD

Professor and Head of the Division of Pediatric Allergy and Immunology, Department of Pediatrics at University of Colorado Denver School of Medicine, Denver, United States

Carocell Bio Support team

Graham Combe
Business Development Director

graham combe carocell bio

Jane Davies, RN, RM
Project Assistant

Simon Bradbury
Patent Advisor

Partner at Appleyard Lees, Manchester

Ruth James, AAC
Financial Advisor

Dave Black
Marketing Consultant

Partner at Onside Creative

Sue Streatfield
Legal Advisor

Partner at Clarion Solicitors, Leeds